286 related articles for article (PubMed ID: 8553535)
41. Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach.
Wu WH; Alkutkar T; Karanam B; Roden RB; Ketner G; Ibeanu OA
Virol J; 2015 Sep; 12():140. PubMed ID: 26362430
[TBL] [Abstract][Full Text] [Related]
42. Sequence conservation within the major capsid protein of human papillomavirus (HPV) type 18 and formation of HPV-18 virus-like particles in Saccharomyces cerevisiae.
Hofmann KJ; Neeper MP; Markus HZ; Brown DR; Müller M; Jansen KU
J Gen Virol; 1996 Mar; 77 ( Pt 3)():465-8. PubMed ID: 8601783
[TBL] [Abstract][Full Text] [Related]
43. Nuclear localization but not PML protein is required for incorporation of the papillomavirus minor capsid protein L2 into virus-like particles.
Becker KA; Florin L; Sapp C; Maul GG; Sapp M
J Virol; 2004 Feb; 78(3):1121-8. PubMed ID: 14722267
[TBL] [Abstract][Full Text] [Related]
44. Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography.
Baek JO; Seo JW; Kim IH; Kim CH
Protein Expr Purif; 2011 Feb; 75(2):211-7. PubMed ID: 20716445
[TBL] [Abstract][Full Text] [Related]
45. Cell surface-binding motifs of L2 that facilitate papillomavirus infection.
Yang R; Day PM; Yutzy WH; Lin KY; Hung CF; Roden RB
J Virol; 2003 Mar; 77(6):3531-41. PubMed ID: 12610128
[TBL] [Abstract][Full Text] [Related]
46. Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes.
Kondo K; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
J Med Virol; 2008 May; 80(5):841-6. PubMed ID: 18360909
[TBL] [Abstract][Full Text] [Related]
47. Assembly of viroplasm and virus-like particles of rotavirus by a Semliki Forest virus replicon.
Nilsson M; von Bonsdorff CH; Weclewicz K; Cohen J; Svensson L
Virology; 1998 Mar; 242(2):255-65. PubMed ID: 9514960
[TBL] [Abstract][Full Text] [Related]
48. Efficient intracellular assembly of papillomaviral vectors.
Buck CB; Pastrana DV; Lowy DR; Schiller JT
J Virol; 2004 Jan; 78(2):751-7. PubMed ID: 14694107
[TBL] [Abstract][Full Text] [Related]
49. Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein.
Kieback E; Müller M
Virology; 2006 Feb; 345(1):199-208. PubMed ID: 16257028
[TBL] [Abstract][Full Text] [Related]
50. Arrangement of L2 within the papillomavirus capsid.
Buck CB; Cheng N; Thompson CD; Lowy DR; Steven AC; Schiller JT; Trus BL
J Virol; 2008 Jun; 82(11):5190-7. PubMed ID: 18367526
[TBL] [Abstract][Full Text] [Related]
51. HPV16 L2 improves HPV16 L1 gene delivery as an important approach for vaccine design against cervical cancer.
Namvar A; Bolhassani A; Hashemi M
Bratisl Lek Listy; 2016; 117(3):179-84. PubMed ID: 26925750
[TBL] [Abstract][Full Text] [Related]
52. Sequence variation in the capsid protein genes of human papillomavirus type 16.
Pushko P; Sasagawa T; Cuzick J; Crawford L
J Gen Virol; 1994 Apr; 75 ( Pt 4)():911-6. PubMed ID: 8151305
[TBL] [Abstract][Full Text] [Related]
53. [Efficient expression of human papillomavirus type 16 (HPV16) capsid proteins L1 and L2 in E. coli].
Wang W; Zhou L; Sun Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):358-61. PubMed ID: 12759977
[TBL] [Abstract][Full Text] [Related]
54. Expression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisae.
Neeper MP; Hofmann KJ; Jansen KU
Gene; 1996 Nov; 180(1-2):1-6. PubMed ID: 8973339
[TBL] [Abstract][Full Text] [Related]
55. Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7.
Daemen T; Riezebos-Brilman A; Bungener L; Regts J; Dontje B; Wilschut J
Vaccine; 2003 Mar; 21(11-12):1082-8. PubMed ID: 12559783
[TBL] [Abstract][Full Text] [Related]
56. Production of human papillomavirus type 45 virus-like particles in insect cells using a recombinant baculovirus.
Touzé A; Dupuy C; Chabaud M; Le Cann P; Coursaget P
FEMS Microbiol Lett; 1996 Jul; 141(1):111-6. PubMed ID: 8764516
[TBL] [Abstract][Full Text] [Related]
57. Mutational analysis of human papillomavirus type 16 major capsid protein L1: the cysteines affecting the intermolecular bonding and structure of L1-capsids.
Ishii Y; Tanaka K; Kanda T
Virology; 2003 Mar; 308(1):128-36. PubMed ID: 12706096
[TBL] [Abstract][Full Text] [Related]
58. The L1 protein of human papilloma virus 16 expressed by a fowlpox virus recombinant can assemble into virus-like particles in mammalian cell lines but elicits a non-neutralising humoral response.
Bissa M; Zanotto C; Pacchioni S; Volonté L; Venuti A; Lembo D; De Giuli Morghen C; Radaelli A
Antiviral Res; 2015 Apr; 116():67-75. PubMed ID: 25660110
[TBL] [Abstract][Full Text] [Related]
59. Virus-like particles and E1-E4 protein expressed from the human papillomavirus type 11 bicistronic E1-E4-L1 transcript.
Brown DR; Pratt L; Bryan JT; Fife KH; Jansen K
Virology; 1996 Aug; 222(1):43-50. PubMed ID: 8806486
[TBL] [Abstract][Full Text] [Related]
60. Study of infectious virus production from HPV18/16 capsid chimeras.
Chen HS; Bromberg-White J; Conway MJ; Alam S; Meyers C
Virology; 2010 Sep; 405(2):289-99. PubMed ID: 20598725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
